In agreement with the biochemical evidence, brain tissues from young AxD patients stained intensely for cleaved GFAP, while the signal was significantly weaker in AxD patients who were older (Figure 9F; Figure 9—figure supplement 1). This evidence concerns the gene GFAP and Alexander disease.